| Breakdown | TTM | Mar 2025 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.43B | 7.17B | 6.26B | 1.23B | 395.40M | 3.58B |
| Gross Profit | 893.30M | 898.70M | 841.20M | -147.90M | -264.90M | 503.30M |
| EBITDA | 937.90M | 933.30M | 849.20M | -172.00M | -165.70M | 497.50M |
| Net Income | 454.10M | 446.80M | 399.20M | -315.40M | -271.20M | 116.00M |
Balance Sheet | ||||||
| Total Assets | 6.27B | 5.91B | 5.57B | 3.99B | 2.87B | 3.38B |
| Cash, Cash Equivalents and Short-Term Investments | 3.35B | 3.15B | 3.18B | 2.23B | 1.38B | 1.39B |
| Total Debt | 1.27B | 1.14B | 1.46B | 1.57B | 1.32B | 1.16B |
| Total Liabilities | 4.21B | 4.30B | 4.16B | 3.10B | 1.91B | 2.75B |
| Stockholders Equity | 2.06B | 1.61B | 1.41B | 896.60M | 964.20M | 634.10M |
Cash Flow | ||||||
| Free Cash Flow | 372.00M | 659.10M | 685.50M | 642.60M | -872.20M | 205.00M |
| Operating Cash Flow | 853.40M | 1.06B | 1.09B | 751.00M | -834.80M | 443.10M |
| Investing Cash Flow | -687.00M | -613.90M | -482.30M | -1.29B | 41.10M | -185.60M |
| Financing Cash Flow | -633.80M | -696.60M | -124.60M | 201.00M | 797.40M | -88.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £2.07B | 1.18 | 24.73% | 1.18% | 7.17% | -2.22% | |
71 Outperform | £3.32B | 26.72 | 17.89% | 1.21% | 14.60% | 58.84% | |
68 Neutral | £1.51B | 14.01 | 20.47% | 3.34% | 8.06% | 5.15% | |
66 Neutral | £3.78B | 6.31 | 7.68% | 3.80% | -2.12% | 8.95% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
48 Neutral | £1.35B | -18.43 | -59.21% | 2.50% | 5.98% | -371.14% | |
46 Neutral | £698.16M | -6.05 | -11.61% | 4.48% | -19.03% | -318.35% |